New Results
Fibroblasts and Alectinib switch the evolutionary games played by non-small cell lung cancer
Artem Kaznatcheev, Jeffrey Peacock, David Basanta, Andriy Marusyk, View ORCID ProfileJacob G. Scott
doi: https://doi.org/10.1101/179259
Artem Kaznatcheev
1Department of Computer Science, University of Oxford
2Department of Translational Hematology & Oncology Research, Cleveland Clinic
Jeffrey Peacock
3Department of Radiation Oncology, Moffitt Cancer Center
David Basanta
4Department of Integrated Mathematical Oncology, Moffitt Cancer Center
Andriy Marusyk
5Department of Cancer Imaging and Metabolism, Moffitt Cancer Center
Jacob G. Scott
2Department of Translational Hematology & Oncology Research, Cleveland Clinic
6Department of Radiation Oncology, Cleveland Clinic
Article usage
Posted October 14, 2018.
Fibroblasts and Alectinib switch the evolutionary games played by non-small cell lung cancer
Artem Kaznatcheev, Jeffrey Peacock, David Basanta, Andriy Marusyk, Jacob G. Scott
bioRxiv 179259; doi: https://doi.org/10.1101/179259
Subject Area
Subject Areas
- Biochemistry (11700)
- Bioengineering (8715)
- Bioinformatics (29120)
- Biophysics (14927)
- Cancer Biology (12047)
- Cell Biology (17347)
- Clinical Trials (138)
- Developmental Biology (9405)
- Ecology (14140)
- Epidemiology (2067)
- Evolutionary Biology (18262)
- Genetics (12216)
- Genomics (16761)
- Immunology (11840)
- Microbiology (27999)
- Molecular Biology (11549)
- Neuroscience (60784)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3228)
- Physiology (4937)
- Plant Biology (10382)
- Synthetic Biology (2876)
- Systems Biology (7332)
- Zoology (1642)